ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Lantheus Holdings Inc

Lantheus Holdings Inc (LNTH)

89,285
-2,66
(-2,89%)
Geschlossen 21 Dezember 10:00PM
89,52
0,235
(0,26%)
Nach Börsenschluss: 1:59AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
89,285
Gebot
87,23
Fragen
89,80
Volumen
2.068.588
88,5607 Tagesbereich 91,69
50,20 52-Wochen-Bereich 126,8899
Marktkapitalisierung
Handelsende
91,94
Handelsbeginn
91,22
Letzte Trade
1
@
89.8
Letzter Handelszeitpunkt
Finanzvolumen
US$ 185.821.924
VWAP
89,8303
Durchschnittliches Volumen (3 Mio.)
1.006.293
Ausgegebene Aktien
69.526.841
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
19,01
Gewinn pro Aktie (EPS)
4,7
Erlöse
1,3B
Nettogewinn
326,66M

Über Lantheus Holdings Inc

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in ... Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States. Mehr anzeigen

Sektor
In Vitro,in Vivo Diagnostics
Branche
In Vitro,in Vivo Diagnostics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Lantheus Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker LNTH. The last closing price for Lantheus was US$91,94. Over the last year, Lantheus shares have traded in a share price range of US$ 50,20 to US$ 126,8899.

Lantheus currently has 69.526.841 shares in issue. The market capitalisation of Lantheus is US$6,39 billion. Lantheus has a price to earnings ratio (PE ratio) of 19.01.

LNTH Neueste Nachrichten

Lantheus Announces Share Repurchase Program

BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling...

Lantheus to Present at the Jefferies London Healthcare Conference

BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...

Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

BEDFORD, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.91-2.0944130708991.19596.06589.285111587992.30789209CS
40.5910.66633594155288.69496.06586.7298453290.80562299CS
12-16.745-15.7927001792106.03118.2175100629394.32959266CS
268.40510.391938674680.88126.8899751032187100.09199736CS
5229.98550.564924114759.3126.889950.2102030782.38265853CS
15662.655235.2797596726.63126.889923.51107910071.87403899CS
26068.185323.15165876821.1126.88998.6785585558.62451481CS

LNTH - Frequently Asked Questions (FAQ)

What is the current Lantheus share price?
The current share price of Lantheus is US$ 89,285
How many Lantheus shares are in issue?
Lantheus has 69.526.841 shares in issue
What is the market cap of Lantheus?
The market capitalisation of Lantheus is USD 6,39B
What is the 1 year trading range for Lantheus share price?
Lantheus has traded in the range of US$ 50,20 to US$ 126,8899 during the past year
What is the PE ratio of Lantheus?
The price to earnings ratio of Lantheus is 19,01
What is the cash to sales ratio of Lantheus?
The cash to sales ratio of Lantheus is 4,79
What is the reporting currency for Lantheus?
Lantheus reports financial results in USD
What is the latest annual turnover for Lantheus?
The latest annual turnover of Lantheus is USD 1,3B
What is the latest annual profit for Lantheus?
The latest annual profit of Lantheus is USD 326,66M
What is the registered address of Lantheus?
The registered address for Lantheus is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Lantheus website address?
The website address for Lantheus is www.lantheus.com
Which industry sector does Lantheus operate in?
Lantheus operates in the IN VITRO,IN VIVO DIAGNOSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock